The Netherlands: Europe’s most attractive and innovative biopharmaceutical industry environment
With an unrivalled concentration of biopharmaceutical ecosystems, world-class universities and a long history of strategic partnerships between science, industry and government, the Netherlands is a perfect location for biopharmaceutical innovation in Europe. Many ground-breaking companies have already established themselves in the Netherlands. The EMA has followed in their footsteps and is relocated to Amsterdam. This confirms once more that the Netherlands is the perfect home for biopharmaceutical companies all around the globe.
Read all about the advantages of setting up your business in the Netherlands in this special bid book for the biopharmaceutical industry. It demonstrates all the reasons why the Netherlands is a top location for pharmaceutical operations for those biopharmaceutical companies that are interested in locating their company in the Netherlands. Read the bid book here:
The following partners have contributed to the development of the bid book: AmCham, Association Innovative Medicines, Health~Holland, HollandBIO, Lygature, Ministry of Economic Affairs and Climate Policy, Netherlands Foreign Investment Agency, VNO-NCW.